<DOC>
	<DOC>NCT00189436</DOC>
	<brief_summary>Subjects aged 1-8 years who have been discharged from the emergency department/outpatient care facility with a diagnosis of asthma/bronchospasm/wheezing after usual standard care will be enrolled into this open-label, randomized, parallel-group study to compare the efficacy of nebulized budesonide and oral corticosteroids in preventing asthma exacerbation relapse rates during the 21-day follow-up period.</brief_summary>
	<brief_title>Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children</brief_title>
	<detailed_description>Secondary outcomes include urinary cortisol-creatinine rations, symptom severity scores and peak flow rates.</detailed_description>
	<mesh_term>Respiratory Sounds</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Children ages 18 years old Discharge from emergency department/outpatient clinic with a diagnosis of asthma exacerbation after usual standard care Subjects must be able to show efficient use with a jet nebulizer Subjects requiring hospitalization Subjects receiving oral steroids 1 week prior to presentation to emergency department. Subjects with FEV1 &lt; 50% of predicted Subjects with comorbid medical conditions (renal or cardiovascular disease) Subjects with reported history of HIV Subjects unable to follow up for study visits Subjects who are frequently enuretic</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Asthma</keyword>
</DOC>